Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.56 (
caspase-3
)
35,750
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated intracellular signaling events involved in fibronectin-accelerated TNF-alpha-mediated PMN apoptosis by means of 2-D gel electrophoresis and western blotting. Proteins were sequenced with electrospray ionization mass spectrometry. Apoptosis was quantitated by flow cytometry. We detected a cluster of acidic, high molecular-weight proteins that were only tyrosine phosphorylated when TNF-alpha-treated PMN interacted with fibronectin. Sequence analysis revealed that one of these proteins was
Ly-GDI
, a regulator of Rho GTPases. Fibronectin increased the TNF-alpha-induced
Ly-GDI
cleavage, yielding a 23-kD fragment. At 8 h, intact
Ly-GDI
was decreased to 33% on fibronectin, compared with 69% on PolyHema (P<0.05). Inhibition of tyrosine phosphorylation prevented phosphorylation of
Ly-GDI
, fibronectin-accelerated
Ly-GDI
cleavage, and fibronectin-accelerated apoptosis in TNF-alpha-treated PMN. We found that
Ly-GDI
cleavage was dependent on
caspase-3
activation and that
caspase-3
inhibition decreased apoptosis. We conclude that tyrosine phosphorylation of
Ly-GDI
, followed by increased
caspase-3
-mediated
Ly-GDI
cleavage, is a signaling event associated with accelerated TNF-alpha-mediated apoptosis on fibronectin.
...
PMID:TNF-alpha-mediated neutrophil apoptosis involves Ly-GDI, a Rho GTPase regulator. 1094 73
Jurkat T cells induced to undergo apoptosis by the CD95(Fas/Apo-1) pathway were investigated by proteome analysis. The most prominent differing protein spots of apoptotic and nonapoptotic cells were identified as various heterogeneous ribonuclear proteins (hnRNPs) and Rho guanin nucleotide dissociation inhibitor (GDI) 2. In apoptotic cells, four spots slightly differing in molecular mass and/or isoelectric point were identified as
Rho GDI 2
with the mass and pI as expected after
caspase-3
cleavage near the N-terminus. Subcellular proteome analysis revealed that
Rho GDI 2
was highly enriched in the cytosolic fraction, present in minor amounts in the nuclear fraction and absent from the mitochondrial fraction. In apoptotic cells however, the spots representing processed and modified
Rho GDI 2
were found in the cytosol, in the nucleus and also the mitochondria at different spot positions. In addition, twelve different hnRNPs were identified to be altered after induction of cell death of which hnRNPs A/B, D, F, H, I and L were hitherto unknown to be modified during apoptosis. Most of the hnRNP spots were found in the nucleus of nonapoptotic cells, whereas these proteins, either modified or unmodified, relocated to the cytosol and/or the mitochondria in apoptotic cells. Our results demonstrate that modification of proteins during apoptosis is often accompanied by their relocalisation between cellular compartments.
...
PMID:Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. 1220 95
RhoGDI2
, a cytosolic regulator of Rho GTPase, is cleaved during apoptosis in a
caspase-3
dependent fashion. By using 2D-gel electrophoresis, mass spectrometry and Western blotting we investigate in this paper the functional consequences of
RhoGDI2
processing. We can show that loss of the N-terminal 19 amino acids results in a shift of the isoelectric point of the truncated
RhoGDI2
(NDelta19) to a more basic value due to the removal of 9 acidic amino acids from the N-terminus, which may be responsible for enhanced retention of the N-terminally truncated protein within the nuclear compartment. Fusion of the p53 nuclear export signaling sequence MFRELNEALELK to NDelta19 (NDelta19NES) abolished its apoptosis promoting properties, while overexpression of NDelta19 significantly increased the susceptibility to apoptosis induction by the proteasome inhibitor PSI and by staurosporine. These results suggest that cleavage of
RhoGDI2
by
caspase-3
is not a functionally irrelevant bystander effect of caspase activation during apoptosis, but rather expedites progression of the apoptotic process.
...
PMID:Functional implications of caspase-mediated RhoGDI2 processing during apoptosis of HL60 and K562 leukemia cells. 1772 46